Effect of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus-Infected Persons: Results From ERCHIVES. [electronic resource]
Producer: 20180223Description: 1006-1011 p. digitalISSN:- 1537-6591
- 2-Naphthylamine
- Aged
- Anilides -- therapeutic use
- Antiviral Agents -- therapeutic use
- Benzimidazoles -- therapeutic use
- Carbamates -- therapeutic use
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Fluorenes -- therapeutic use
- Hepatitis C, Chronic -- drug therapy
- Humans
- Kaplan-Meier Estimate
- Lactams, Macrocyclic
- Macrocyclic Compounds -- therapeutic use
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Propensity Score
- Proportional Hazards Models
- Ritonavir -- therapeutic use
- Sofosbuvir -- therapeutic use
- Sulfonamides -- therapeutic use
- Survival Rate
- Sustained Virologic Response
- Uracil -- analogs & derivatives
- Valine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.